Myriad Genetics MYGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.1M-332% | -$7.9M+71.2% | -$27.4M+91.7% | -$330.5M-330,400% | -$100K+99.8% | ||
| $12.5M-0.8% | $12.6M0.0% | $12.6M-10.6% | $14.1M-2.1% | $14.4M-2.7% | ||
| $6.5M+132% | $2.8M-77.0% | $12.2M+14.0% | $10.7M+12.6% | $9.5M-12.8% | ||
| -$15.7M-248% | $10.6M-49.8% | $21.1M+255% | -$13.6M+16.6% | -$16.3M— | ||
| -$6.5M-8.3% | -$6M+3.2% | -$6.2M+10.1% | -$6.9M+16.9% | -$8.3M-40.7% | ||
| $0— | —— | —— | —— | $40M+100% | ||
| $0— | —— | $60M— | —— | $20.5M+5.1% | ||
| -$3M— | —— | $56.2M+2,062% | $2.6M-80.9% | $13.6M— | ||
| -$25.3M— | $0-100% | $71.1M+511% | -$17.3M-58.7% | -$10.9M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
